Transcriptome dataset of two Pistacia species: Pistacia chinensis and Pistacia weinmannifolia .

Autor: Suliyat AB; Department of Agriculture and Industries, Graduate School, Kangwon National University, Chuncheon 24341, South Korea., Anggita DK; Department of Agriculture and Industries, Graduate School, Kangwon National University, Chuncheon 24341, South Korea., Yang HS; Department of Agriculture and Industries, Graduate School, Kangwon National University, Chuncheon 24341, South Korea., Lee SW; International Biological Material Research Center, KRIBB, Daejeon 34141, South Korea.; Institute of Medicinal Plants, Yunnan Academy of Agricultural Sciences, Kunming, Yunnan 650200, PR China., Li WY; Institute of Medicinal Plants, Yunnan Academy of Agricultural Sciences, Kunming, Yunnan 650200, PR China., Choi SH; International Biological Material Research Center, KRIBB, Daejeon 34141, South Korea., Choi KY; Department of SmartFarm and Agricultural Industries, Kangwon National University, Chuncheon, Kangwon 24341, South Korea., Na JK; Department of Agriculture and Industries, Graduate School, Kangwon National University, Chuncheon 24341, South Korea.; Department of SmartFarm and Agricultural Industries, Kangwon National University, Chuncheon, Kangwon 24341, South Korea.
Jazyk: angličtina
Zdroj: Data in brief [Data Brief] 2023 Dec 22; Vol. 52, pp. 110002. Date of Electronic Publication: 2023 Dec 22 (Print Publication: 2024).
DOI: 10.1016/j.dib.2023.110002
Abstrakt: Pistacia chinensis and Pistacia weinmannifolia are small trees and are distributed in East Asia, in particular China. The data on P. chinensis presented in this article is associated with the research article, "DOI: 10.5010/JPB.2019.46.4.274" [1]. Both P. chinensis and P. weinmannifolia have long been used as ethnobotanical plants to treat various illnesses, including dysentery, inflammatory swelling, rheumatism, liver diseases, influenza, lung cancer, etc. Many studies have been carried out to delve into the pharmaceutical properties of these Pistacia species using plant extracts, but genomic studies are very rarely performed to date. To enrich the genetic information of these two species, RNA sequencing was conducted using a pair-end Illumina HiSeq2500 sequencing system, resulting in 2.6 G of raw data from P. chinensis (Accession no: SRR10136265) and 2.7 G bases from P. weinmannifolia (Accession no: SRR10136264). Transcriptome shotgun assembly using three different assembly tools generated a total of 18,524 non-redundant contigs (N50, 1104 bp) from P. chinensis and 18,956 from P. weinmannifolia (N50, 1137 bp). The data is accessible at NCBI BioProject: PRJNA566127. These data would be crucial for the identification of genes associated with the compounds exerting pharmaceutical properties and also for molecular marker development.
(© 2023 The Author(s).)
Databáze: MEDLINE